Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

View source ↗

Summary

This clinical trial update outlines the optimization and validation of quality control indicators for management of coronary revascularization based on antiplat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Acute Coronary Syndrome (ACS), High Bleeding Risk (HBR) | Status: NOT_YET_RECRUITING